Markey's Blackburn Earns NIH New Innovator Award for Cancer Research
University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.
KEHA Marks 40 Years of Support for UK Ovarian Cancer Research
A fundraising effort that began with an impassioned plea from one extension homemaker to her peers has positively impacted Kentucky women and the University of Kentucky for the past 40 years.
Cheavar Blair successfully earns his Doctoral degree
On October 3, 2017, Cheavar Blair successfully earned his Doctoral Degree. By doing so, he has become the first African-American male in the history of the Department of Physiology to be awarded a PhD. Congratulations Dr. Blair!
THE MECHANICAL PROPERTIES OF NON-FAILING AND FAILING HUMAN MYOCARDIUM
Doctoral Committee Members
Dr. Ken Campbell
Department of Physiology
Dr. John McCarthy
Department of Physiology
Dr. Tim McClintock
Department of Physiology
Upcoming Deadlines for Universal Tuition Program
[From the UK Graduate School]
New Limited Submission Portal Now Available
Check Out the New Limited Submissions Portal!
UK Research has just launched a new online limited submissions portal at Limited Submissions Opportunities on the Proposal Development Office website.
New Subaward Invoice Process Live Now
Research Financial Services has been leading a team with Enterprise Applications Group (EAG) and Office of Sponsored Projects Administration to create efficiency in processing subaward invoices, while meeting federal compliance standards. The EAG team developed an outstanding program to establish electronic approval for subaward invoices. The pilot has successfully been completed and effective September 29, all subaward invoices will be under the new process.
Funding Opportunity Announced for COCVD
THE CENTER FOR BIOMEDICAL RESEARCH EXCELLENCE ON OBESITY AND CARDIOVASCULAR DISEASES (COCVD) FUNDING OPPORTUNITY
UK Researchers Seek to Identify Ways to Relieve Post-Chemotherapy Cognitive Impairment
Of the 14 million cancer survivors in the United States, a significant number experience a serious side effect called chemotherapy-induced cognitive impairment (CICI). While easily recognized, little is known about the etiology of this condition, also known informally as “chemo brain.” CICI can significantly reduce patients’ quality of life with serious, even devastating, symptoms such as memory lapses, difficulty concentrating, negative impacts on multitasking, confusion and fatigue.